Spravato® REMS requirements,
explained in plain language.

Why Spravato® has a REMS at all

Esketamine carries real, well-characterized risks in the hours after a dose — sedation, dissociation, and blood-pressure elevation — alongside its potential for misuse. The FDA approved it on the condition that it is never simply handed to a patient: every dose is self-administered under direct supervision in a certified healthcare setting, the patient is monitored on site afterwards, and the session is documented to the REMS program. That bargain — access in exchange for provable supervision — is the entire shape of the program.

The four pillars of compliance

• Certified setting. The clinic (and its pharmacy channel) must be certified with the REMS program before any product is dispensed or administered. Certification carries obligations — trained staff, monitoring capability, and documentation — that the program can audit.
• Enrolled patients. Every patient is enrolled in the REMS before their first treatment, acknowledging the monitoring requirements and the restriction on driving until the next day, after a restful sleep.
• The supervised, monitored session. The patient self-administers the nasal spray under supervision, then remains on site for monitoring — at least two hours — until they're clinically stable to leave with their arranged ride home.
• The Patient Monitoring Form. Each session is documented on the program's monitoring form — vitals, observations, any serious adverse events — and submitted to the REMS program within seven calendar days.

What a treatment day owes the program

On the day itself, the requirements concentrate into a sequence every clinic comes to know by heart: confirm the patient's enrollment and transport home; take pre-dose blood pressure; supervise the dosing, device by device, with the rest the label calls for between devices; start the observation clock; re-check blood pressure around the forty-minute mark and again before discharge; record sedation, dissociation, and any other observations as they happen; review whether anything rose to a serious adverse event; and only then discharge — at least two hours after the dose, to a patient who isn't driving.

None of those steps is individually hard. The difficulty is that they repeat for every room, every session, every day — on a clock that doesn't pause — and that the record of them has to be accurate enough to survive scrutiny later. A misread vital transcribed from a clipboard, a monitoring window cut short by a busy afternoon, or a form that slips past its deadline are all, in the program's eyes, the same thing: a compliance failure by a certified setting.

Who does what

• The prescriber determines treatment, handles enrollment, and signs off on clinical judgments — including any decision to dose outside normal parameters.
• The administering clinician (often an RN or NP) runs the session: checklist, vitals, supervised dosing, observations, and the discharge assessment.
• The front desk keeps the floor moving — who's arriving, which room is in which phase, which forms are still unfiled.
• The clinic itself — as the certified setting — owns the obligation. Individual diligence doesn't transfer; the setting's records do.

Paper, spreadsheets, or software

The program doesn't mandate any particular tooling — a clipboard and a kitchen timer are, formally, compliant instruments. The question is whether they produce a defensible record: timestamps a reviewer can trust, a monitoring window that provably ran its full length, and forms that demonstrably met their deadline. That's the gap purpose-built tooling closes — not by changing what the program asks, but by making the proof a by-product of running the day instead of a second job after it.

Related guides

• The two-hour monitoring window: what it actually requires
• The seven-day filing deadline, and how clinics miss it
• Starting a Spravato® clinic: the compliance checklist